Zhangzhou Pientzehuang Pharmaceutical., Ltd Stock price

Equities

600436

CNE000001F21

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
230.6 CNY -0.12% Intraday chart for Zhangzhou Pientzehuang Pharmaceutical., Ltd -2.11% -4.71%
Sales 2023 10.03B 1.39B Sales 2024 * 11.73B 1.62B Capitalization 139B 19.26B
Net income 2023 2.78B 385M Net income 2024 * 3.45B 478M EV / Sales 2023 14.5 x
Net cash position 2023 * 4.14B 573M Net cash position 2024 * 5.38B 744M EV / Sales 2024 * 11.4 x
P/E ratio 2023
52.5 x
P/E ratio 2024 *
39.9 x
Employees 2,720
Yield 2023 *
0.63%
Yield 2024 *
0.73%
Free-Float 38.58%
More Fundamentals * Assessed data
Dynamic Chart
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. Signs Cooperation Agreement with Beijing Tong Ren Tang Group CI
Pientzehuang Pharmaceutical's Profit Climbs 12.6% in 2023 MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhangzhou Pientzehuang to Raise Price of Multifunctional TCM by 29% MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pientzehuang Logs Slowest Profit Growth in 12 Years MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pien Tze Huang Pharma’s Q3 Profit Falls 18% as Revenue Slips 3% MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
FTSE Russell makes additions including PetroChina in review of China indices RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day-0.12%
1 week-2.11%
Current month+3.41%
1 month+5.29%
3 months-5.22%
6 months-16.21%
Current year-4.71%
More quotes
1 week
229.00
Extreme 229
234.56
1 month
221.70
Extreme 221.7
240.67
Current year
180.69
Extreme 180.69
242.98
1 year
180.69
Extreme 180.69
321.00
3 years
180.69
Extreme 180.69
491.88
5 years
90.96
Extreme 90.96
491.88
10 years
19.63
Extreme 19.6267
491.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-04-17
Director/Board Member 58 10-06-30
Director/Board Member 59 86-07-31
Members of the board TitleAgeSince
Director/Board Member 64 22-01-19
Chief Executive Officer 58 16-04-17
Director/Board Member 48 18-03-28
More insiders
Date Price Change Volume
24-03-28 230.6 -0.12% 1,616,032
24-03-27 230.9 -0.56% 1,255,533
24-03-26 232.2 +0.43% 1,282,602
24-03-25 231.2 -1.17% 1,132,974
24-03-22 233.9 -0.71% 1,726,830

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is specialized in developing and marketing traditional Chinese medicine products. The company offers medicines and health products, cosmetic products, dietary compounds, etc.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
230.6 CNY
Average target price
295.9 CNY
Spread / Average Target
+28.30%
Consensus
  1. Stock
  2. Equities
  3. Stock Zhangzhou Pientzehuang Pharmaceutical., Ltd - Shanghai S.E.